2nd Edition of Cell & Gene Therapy World Conference(CGTWC) 2026

Scientific Sessions

Clinical Translation of Regenerative Medicine: Challenges, Outcomes, and Future Directions

Clinical translation of regenerative medicine represents the definitive bridge between scientific discovery and patient impact. Despite significant progress in stem cell biology, regenerative medicine, and gene-modified therapies, the road to clinical application is laden with challenges, including regulatory hurdles, scalability of manufacturing, long-term safety and efficacy, and reimbursement. At our Cell & Gene Therapy event, the discussion will provide a perspective into how scientific innovation, evidence-informed evaluation, and collaborative multi-disciplinary science can propel the safe and effective implementation of regenerative medicine into mainstream clinical practice.

Related Sessions

CRISPR Cas9 and Beyond: Emerging Genome Editing Platforms
Precision Genome Editing: From Target Discovery to Clinical Application
Engineering the Immune System: Gene and Cell Based Modulation
Non Viral Gene Delivery Strategies: Safety, Scalability, and Translation
Stem Cell Derived Therapeutics: iPSCs, Organoids and Tissue Engineering
Allogeneic vs Autologous Cell Therapies: Manufacturing, Efficacy, and Access
Manufacturing for Personalized Medicine: Customised Cell Products at Scale
Analytics, Potency Assays, and Rapid Release Strategies
CGTs for Monogenic Disorders: Delivering the Cure
Gene and Cell Therapies in Oncology: CAR T, NK, TCR, Oncolytic Approaches
Neurological and Neurodegenerative Disease Applications of CGTs
Market Access, Health Economics, and Reimbursement in CGT
Global Access and Equity: Bridging the CGT Innovation Gap
The Future Landscape of Cell and Gene Therapies: 2030 and Beyond
Cell and Gene Therapy Clinical Development
Cell and Gene Therapy Pipeline Analysis